→ PR → News
News
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX, Submission of New Drug Application in Korea and Approval for Clinical Trial Phase3 IND in Russia
Protox’s botulinum toxin preparation ‘Protoxin Inj. (tentative name)’ is speeding up commercialization. It has applied for approval in Korea and was approved for phase 3 in Russia. The analysis is that Protox’s two-track commercialization strategy at …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX receives the Ministerial Award for Outstanding Contribution to Biological Security Management.
Protox was selected as the best among institutions with excellent biological security management as a result of ‘regular (occasional) inspection of biological agents, etc.’ over the past three years and received the Minister of …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX signs an exclusive supply contract with Brazil and Russia for botulinum toxin ‘Protoxin Inj.’
Protox, a company specializing in manufacturing botulinum toxin drugs, announced on the 17th that it has signed an exclusive supply contract between Brazil and Russia for its own botulinum toxin type A (tentative name …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX, Botulinum toxin ‘Protoxin Inj.’ phase 3 clinical trial approved by Pusan National University Hospital IRB
Protox, a DSK subsidiary, announced on the 20th that it has received IRB (Clinical Research Review Committee) approval from Pusan National University Hospital for phase 3 clinical trials of botulinum toxin type A “Protoxin”. …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX obtained Approval for Phase 3 Clinical Trial Plan(IND) of Botulinum Toxin ‘Protoxin Inj.’
Protox’s botulinum toxin A formulation ‘Protoxin’ will soon enter phase 3 clinical trials. The Ministry of Food and Drug Safety submitted a report submitted by Protox on the 1st, titled ‘Multicenter, double-blind, random allocation …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX, ‘Protoxin Injection’ phase 2 clinical trial Initiation…Validation of Efficacy of wrinkles between the eyes
Protox, a biopharmaceutical affiliate of Synergy Partners Group, announced on the 3rd that it will successfully end phase 1 clinical trial of its own botulinum toxin type A, “Protoxin” and begin phase 2 clinical …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
Ministry of Food and Drug Safety grants export permission for PROTOX ‘Protoxin’
Protox received permission to export Protoxin. According to the Ministry of Food and Drug Safety’s Integrated Drug Information System, product approval was granted for export of Protox ‘Protoxin Injection 100 Units (Clostridium Botulinum Toxin …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX, obtained clinical trial plan(IND) and GMP approval for Botulinum Toxin
Protox, a biopharmaceutical company, announced on the 3rd that it has obtained clinical plan approval and GMP approval for Protoxin, a botulinum toxin drug, from the Ministry of Food and Drug Safety, as of …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX applies for botulinum toxin clinical trial
Protox announced on the 27th that it has submitted an application to the Ministry of Food and Drug Safety for approval of phase 1/2 clinical trial plan (IND), GMP certification, and export license of …
Read More (currently in Korean only)
Warning: Illegal string offset 'url' in /www_root/wp-content/plugins/elementor/includes/base/controls-stack.php on line 1201
PROTOX enters Phase 1 clinical trial of Botox in April and applies for GMP certification
Protox, a DSK subsidiary, is expected to apply for a phase 1 clinical trial this month to develop botulinum toxin (Botox).It also applies for GMP (Korea Good Manufacturing Practice) certification for export. A DSK …
Read More (currently in Korean only)
